PO3 0.00% 22.0¢ purifloh limited

Stryker to back PuriflOH med-tech?, page-2

  1. 310 Posts.
    lightbulb Created with Sketch. 107
    Excellent summary, the potential of OEM partners and potential customers are on a huge scale Stryker is just one of many options... I remember in an interview with SA where he mentioned that the risk was in the commercialisation well we can see that he is tackling that risk and is getting it low key minimalised on a daily basis, at the current time I believe SA holds all the cards and has technology that everyone is screaming to get their hands on but what has really stood out to me is we know there are so many potential OEM partners and it’s taking a long time which I believe they are all working hard to impress the PO3 board and the board are in tough negotiations to get the best for us share holders if we had any old board we would have OEM partners signed by now but this board are keeping a tight ship and putting the share holders interest first! I believe accumulation is my sentiment at the moment because once patents are valid and OEMS are signed there’s no going back...
 
watchlist Created with Sketch. Add PO3 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.